Sanuwave Health (SNWV) Competitors

$15.64 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$15.71 +0.07 (+0.45%)

As of 06:36 PM Eastern

SNWV vs. BWAY, SIBN, NPCE, TCMD, and EMBC

Should you be buying Sanuwave Health stock or one of its competitors? The main competitors of Sanuwave Health include Brainsway (BWAY), SiBone (SIBN), NeuroPace (NPCE), Tactile Systems Technology (TCMD), and Embecta (EMBC). These companies are all part of the "medical equipment" industry.

How does Sanuwave Health compare to Brainsway?

Sanuwave Health (NASDAQ:SNWV) and Brainsway (NASDAQ:BWAY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

: Sanuwave Health has a net margin of 26.64% compared to Brainsway's net margin of 14.62%. Brainsway's return on equity of 11.10% beat Sanuwave Health's return on equity.
Company Net Margins Return on Equity Return on Assets
Sanuwave Health 26.64% -141.56% 34.53%
Brainsway 14.62% 11.10% 6.97%
: 42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 30.1% of Brainsway shares are held by institutional investors. 14.9% of Sanuwave Health shares are held by company insiders. Comparatively, 19.0% of Brainsway shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
: Sanuwave Health has higher earnings, but lower revenue than Brainsway. Sanuwave Health is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sanuwave Health $44.05M 3.05 $11.81M -$0.16 N/A
Brainsway $52.23M 12.59 $7.57M $0.25 65.68
: In the previous week, Brainsway had 1 more articles in the media than Sanuwave Health. MarketBeat recorded 2 mentions for Brainsway and 1 mentions for Sanuwave Health. Brainsway's average media sentiment score of 0.00 beat Sanuwave Health's score of -0.50 indicating that Brainsway is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sanuwave Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
Brainsway
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Sanuwave Health currently has a consensus price target of $51.00, suggesting a potential upside of 226.09%. Brainsway has a consensus price target of $15.00, suggesting a potential downside of 8.65%. Given Sanuwave Health's higher probable upside, equities research analysts plainly believe Sanuwave Health is more favorable than Brainsway.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanuwave Health
1 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

1 Strong Buy rating(s)
2.50
Brainsway
0 Sell rating(s)

0 Hold rating(s)

3 Buy rating(s)

1 Strong Buy rating(s)
3.25
: Sanuwave Health has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Brainsway has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	26.64%	-141.56%	34.53%
Brainsway	14.62%	11.10%	6.97%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	3.05	$11.81M	-$0.16	N/A
Brainsway	$52.23M	12.59	$7.57M	$0.25	65.68

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Brainsway	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Brainsway	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

Summary

Brainsway beats Sanuwave Health on 10 of the 16 factors compared between the two stocks.

How does Sanuwave Health compare to SiBone?

Sanuwave Health (NASDAQ:SNWV) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

: Sanuwave Health currently has a consensus price target of $51.00, suggesting a potential upside of 226.09%. SiBone has a consensus price target of $24.00, suggesting a potential upside of 77.12%. Given Sanuwave Health's higher probable upside, equities research analysts plainly believe Sanuwave Health is more favorable than SiBone.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanuwave Health
1 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

1 Strong Buy rating(s)
2.50
SiBone
1 Sell rating(s)

0 Hold rating(s)

6 Buy rating(s)

0 Strong Buy rating(s)
2.71
: Sanuwave Health has a net margin of 26.64% compared to SiBone's net margin of -9.41%. SiBone's return on equity of -11.01% beat Sanuwave Health's return on equity.
Company Net Margins Return on Equity Return on Assets
Sanuwave Health 26.64% -141.56% 34.53%
SiBone -9.41% -11.01% -8.12%
: Sanuwave Health has higher earnings, but lower revenue than SiBone. Sanuwave Health is trading at a lower price-to-earnings ratio than SiBone, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sanuwave Health $44.05M 3.05 $11.81M -$0.16 N/A
SiBone $200.93M 2.98 -$18.90M -$0.44 N/A
: 42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 14.9% of Sanuwave Health shares are held by company insiders. Comparatively, 4.0% of SiBone shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
: In the previous week, SiBone had 6 more articles in the media than Sanuwave Health. MarketBeat recorded 7 mentions for SiBone and 1 mentions for Sanuwave Health. SiBone's average media sentiment score of 0.66 beat Sanuwave Health's score of -0.50 indicating that SiBone is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sanuwave Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
SiBone
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
: Sanuwave Health has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	26.64%	-141.56%	34.53%
SiBone	-9.41%	-11.01%	-8.12%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	3.05	$11.81M	-$0.16	N/A
SiBone	$200.93M	2.98	-$18.90M	-$0.44	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
SiBone	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Sanuwave Health beats SiBone on 9 of the 17 factors compared between the two stocks.

How does Sanuwave Health compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

: NeuroPace has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500. Comparatively, Sanuwave Health has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500.
: Sanuwave Health has a net margin of 26.64% compared to NeuroPace's net margin of -21.47%. NeuroPace's return on equity of -105.67% beat Sanuwave Health's return on equity.
Company Net Margins Return on Equity Return on Assets
NeuroPace -21.47% -105.67% -20.01%
Sanuwave Health 26.64% -141.56% 34.53%
: In the previous week, NeuroPace had 2 more articles in the media than Sanuwave Health. MarketBeat recorded 3 mentions for NeuroPace and 1 mentions for Sanuwave Health. NeuroPace's average media sentiment score of 0.00 beat Sanuwave Health's score of -0.50 indicating that NeuroPace is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NeuroPace
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sanuwave Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
: 78.8% of NeuroPace shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 20.5% of NeuroPace shares are held by insiders. Comparatively, 14.9% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
: NeuroPace currently has a consensus price target of $18.67, suggesting a potential upside of 9.55%. Sanuwave Health has a consensus price target of $51.00, suggesting a potential upside of 226.09%. Given Sanuwave Health's higher possible upside, analysts plainly believe Sanuwave Health is more favorable than NeuroPace.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeuroPace
1 Sell rating(s)
1 Hold rating(s)

4 Buy rating(s)

2 Strong Buy rating(s)
2.88
Sanuwave Health
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

1 Strong Buy rating(s)
2.50
: Sanuwave Health has lower revenue, but higher earnings than NeuroPace. Sanuwave Health is trading at a lower price-to-earnings ratio than NeuroPace, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NeuroPace $99.99M 5.79 -$21.47M -$0.66 N/A
Sanuwave Health $44.05M 3.05 $11.81M -$0.16 N/A

Company	Net Margins	Return on Equity	Return on Assets
NeuroPace	-21.47%	-105.67%	-20.01%
Sanuwave Health	26.64%	-141.56%	34.53%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroPace	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.88
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroPace	$99.99M	5.79	-$21.47M	-$0.66	N/A
Sanuwave Health	$44.05M	3.05	$11.81M	-$0.16	N/A

Summary

NeuroPace beats Sanuwave Health on 12 of the 17 factors compared between the two stocks.

How does Sanuwave Health compare to Tactile Systems Technology?

Tactile Systems Technology (NASDAQ:TCMD) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

: In the previous week, Tactile Systems Technology had 9 more articles in the media than Sanuwave Health. MarketBeat recorded 10 mentions for Tactile Systems Technology and 1 mentions for Sanuwave Health. Tactile Systems Technology's average media sentiment score of -0.49 beat Sanuwave Health's score of -0.50 indicating that Tactile Systems Technology is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tactile Systems Technology
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sanuwave Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
: 83.4% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 2.1% of Tactile Systems Technology shares are owned by insiders. Comparatively, 14.9% of Sanuwave Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
: Sanuwave Health has a net margin of 26.64% compared to Tactile Systems Technology's net margin of 5.79%. Tactile Systems Technology's return on equity of 9.26% beat Sanuwave Health's return on equity.
Company Net Margins Return on Equity Return on Assets
Tactile Systems Technology 5.79% 9.26% 7.03%
Sanuwave Health 26.64% -141.56% 34.53%
: Tactile Systems Technology currently has a consensus target price of $37.80, suggesting a potential upside of 57.17%. Sanuwave Health has a consensus target price of $51.00, suggesting a potential upside of 226.09%. Given Sanuwave Health's higher probable upside, analysts clearly believe Sanuwave Health is more favorable than Tactile Systems Technology.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tactile Systems Technology
0 Sell rating(s)
3 Hold rating(s)

3 Buy rating(s)

1 Strong Buy rating(s)
2.71
Sanuwave Health
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

1 Strong Buy rating(s)
2.50
: Tactile Systems Technology has higher revenue and earnings than Sanuwave Health. Sanuwave Health is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Tactile Systems Technology $329.52M 1.66 $19.09M $0.83 28.98
Sanuwave Health $44.05M 3.05 $11.81M -$0.16 N/A
: Tactile Systems Technology has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, Sanuwave Health has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tactile Systems Technology	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	5.79%	9.26%	7.03%
Sanuwave Health	26.64%	-141.56%	34.53%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	1.66	$19.09M	$0.83	28.98
Sanuwave Health	$44.05M	3.05	$11.81M	-$0.16	N/A

Summary

Tactile Systems Technology beats Sanuwave Health on 10 of the 16 factors compared between the two stocks.

How does Sanuwave Health compare to Embecta?

Sanuwave Health (NASDAQ:SNWV) and Embecta (NASDAQ:EMBC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

: Embecta has higher revenue and earnings than Sanuwave Health. Sanuwave Health is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sanuwave Health $44.05M 3.05 $11.81M -$0.16 N/A
Embecta $1.08B 0.21 $95.40M $2.37 1.65
: Sanuwave Health has a net margin of 26.64% compared to Embecta's net margin of 12.92%. Embecta's return on equity of -26.66% beat Sanuwave Health's return on equity.
Company Net Margins Return on Equity Return on Assets
Sanuwave Health 26.64% -141.56% 34.53%
Embecta 12.92% -26.66% 16.06%
: 42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 93.8% of Embecta shares are held by institutional investors. 14.9% of Sanuwave Health shares are held by company insiders. Comparatively, 1.3% of Embecta shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
: In the previous week, Embecta had 11 more articles in the media than Sanuwave Health. MarketBeat recorded 12 mentions for Embecta and 1 mentions for Sanuwave Health. Embecta's average media sentiment score of 0.70 beat Sanuwave Health's score of -0.50 indicating that Embecta is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sanuwave Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
Embecta
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
: Sanuwave Health presently has a consensus target price of $51.00, suggesting a potential upside of 226.09%. Embecta has a consensus target price of $18.50, suggesting a potential upside of 374.36%. Given Embecta's higher possible upside, analysts clearly believe Embecta is more favorable than Sanuwave Health.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanuwave Health
1 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

1 Strong Buy rating(s)
2.50
Embecta
0 Sell rating(s)

4 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Sanuwave Health has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Embecta has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	3.05	$11.81M	-$0.16	N/A
Embecta	$1.08B	0.21	$95.40M	$2.37	1.65

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	26.64%	-141.56%	34.53%
Embecta	12.92%	-26.66%	16.06%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Embecta	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Embecta	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Embecta beats Sanuwave Health on 9 of the 17 factors compared between the two stocks.

Get Sanuwave Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SNWV vs. The Competition

Export

Metric	Sanuwave Health	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$134.50M	$8.14B	$6.25B	$11.87B
Dividend Yield	N/A	2.45%	2.73%	5.21%
P/E Ratio	-97.74	119.73	29.04	28.48
Price / Sales	3.05	7.42	476.48	60.89
Price / Cash	9.27	17.32	27.62	36.52
Price / Book	82.32	3.52	9.67	6.67
Net Income	$11.81M	$223.69M	$3.55B	$332.64M
7 Day Performance	-15.05%	0.07%	1.70%	2.01%
1 Month Performance	-7.46%	10.31%	5.62%	9.19%
1 Year Performance	-49.48%	0.92%	34.42%	39.59%

Sanuwave Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SNWV Sanuwave Health	2.257 of 5 stars	$15.64 flat	$51.00 +226.1%	N/A	$134.50M	$44.05M	N/A	40	Upcoming Earnings
BWAY Brainsway	1.5293 of 5 stars	$16.37 +3.9%	$15.00 -8.4%	N/A	$655.34M	$52.23M	65.48	120
SIBN SiBone	2.288 of 5 stars	$13.52 +0.9%	$24.00 +77.5%	N/A	$598.18M	$200.93M	N/A	350	Upcoming Earnings
NPCE NeuroPace	1.4503 of 5 stars	$16.80 -0.4%	$18.67 +11.1%	N/A	$572.74M	$99.99M	N/A	170	News Coverage Positive News Upcoming Earnings
TCMD Tactile Systems Technology	4.4679 of 5 stars	$25.07 +2.5%	$37.40 +49.2%	N/A	$570.34M	$329.52M	30.20	1,086	Trending News Earnings Report Analyst Forecast Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SNWV) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sanuwave Health (SNWV) Competitors

SNWV vs. BWAY, SIBN, NPCE, TCMD, and EMBC

How does Sanuwave Health compare to Brainsway?

Summary

How does Sanuwave Health compare to SiBone?

Summary

How does Sanuwave Health compare to NeuroPace?

Summary

How does Sanuwave Health compare to Tactile Systems Technology?

Summary

How does Sanuwave Health compare to Embecta?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sanuwave Health (SNWV) Competitors

SNWV vs. BWAY, SIBN, NPCE, TCMD, and EMBC

How does Sanuwave Health compare to Brainsway?

Summary

How does Sanuwave Health compare to SiBone?

Summary

How does Sanuwave Health compare to NeuroPace?

Summary

How does Sanuwave Health compare to Tactile Systems Technology?

Summary

How does Sanuwave Health compare to Embecta?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools